Solid Biosciences Inc. (SLDB)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
4 |
$26,099,164 |
| Sells |
15 |
$293,916 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 13 Mar 2025 |
KAHN CLARE |
Director |
11 Mar 2025 |
1,860 |
5.34 |
9,924 |
| 21 Feb 2025 |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC |
10% |
19 Feb 2025 |
1,000,000 |
4.03 |
4,030,000 |
| 21 Feb 2025 |
PERCEPTIVE ADVISORS LLC |
Director , 10% |
19 Feb 2025 |
5,000,000 |
4.03 |
20,150,000 |
| 19 Feb 2025 |
ADAGE CAPITAL MANAGEMENT, L.P. |
10% |
18 Feb 2025 |
252,545 |
7.56 |
1,909,240 |
| 11 Jun 2024 |
KAHN CLARE |
Director |
07 Jun 2024 |
1,100 |
7.67 |
8,442 |
| 12 Jan 2024 |
PERCEPTIVE ADVISORS LLC |
Director , 10% |
11 Jan 2024 |
3,410,713 |
5.53 |
18,861,243 |
| 12 Jan 2024 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
11 Jan 2024 |
904,160 |
5.53 |
5,000,005 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock